BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28583049)

  • 1. N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus.
    Gobira PH; Lima IV; Batista LA; de Oliveira AC; Resstel LB; Wotjak CT; Aguiar DC; Moreira FA
    J Psychopharmacol; 2017 Jun; 31(6):750-756. PubMed ID: 28583049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant effects of N-arachidonoyl-serotonin, a dual fatty acid amide hydrolase enzyme and transient receptor potential vanilloid type-1 (TRPV1) channel blocker, on experimental seizures: the roles of cannabinoid CB1 receptors and TRPV1 channels.
    Vilela LR; Medeiros DC; de Oliveira AC; Moraes MF; Moreira FA
    Basic Clin Pharmacol Toxicol; 2014 Oct; 115(4):330-4. PubMed ID: 24674273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
    Laricchiuta D; Centonze D; Petrosini L
    Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
    Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
    Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
    Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
    Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice.
    Costa B; Bettoni I; Petrosino S; Comelli F; Giagnoni G; Di Marzo V
    Pharmacol Res; 2010 Jun; 61(6):537-46. PubMed ID: 20138997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats.
    de Novellis V; Palazzo E; Rossi F; De Petrocellis L; Petrosino S; Guida F; Luongo L; Migliozzi A; Cristino L; Marabese I; Starowicz K; Di Marzo V; Maione S;
    Neuropharmacology; 2008 Dec; 55(7):1105-13. PubMed ID: 18616956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT).
    Bashashati M; Fichna J; Piscitelli F; Capasso R; Izzo AA; Sibaev A; Timmermans JP; Cenac N; Vergnolle N; Di Marzo V; Storr M
    Neurogastroenterol Motil; 2017 Dec; 29(12):. PubMed ID: 28695708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1 channel in an in vitro seizure model.
    Nazıroğlu M; Taner AN; Balbay E; Çiğ B
    Mol Cell Biochem; 2019 Mar; 453(1-2):143-155. PubMed ID: 30159798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics.
    Maione S; Costa B; Piscitelli F; Morera E; De Chiaro M; Comelli F; Boccella S; Guida F; Verde R; Ortar G; Di Marzo V
    Pharmacol Res; 2013 Oct; 76():98-105. PubMed ID: 23911581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPV1 modulation of contextual fear memory depends on stimulus intensity and endocannabinoid signalling in the dorsal hippocampus.
    Iglesias LP; Fernandes HB; de Miranda AS; Perez MM; Faccioli LH; Sorgi CA; Bertoglio LJ; Aguiar DC; Wotjak CT; Moreira FA
    Neuropharmacology; 2023 Feb; 224():109314. PubMed ID: 36336070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of CB
    Sartim AG; Moreira FA; Joca SRL
    Neuroscience; 2017 Jan; 340():126-134. PubMed ID: 27771531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis.
    Navarria A; Tamburella A; Iannotti FA; Micale V; Camillieri G; Gozzo L; Verde R; Imperatore R; Leggio GM; Drago F; Di Marzo V
    Pharmacol Res; 2014 Sep; 87():151-9. PubMed ID: 24861565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB
    Stern CAJ; da Silva TR; Raymundi AM; de Souza CP; Hiroaki-Sato VA; Kato L; Guimarães FS; Andreatini R; Takahashi RN; Bertoglio LJ
    Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.
    Kawahara H; Drew GM; Christie MJ; Vaughan CW
    Br J Pharmacol; 2011 Jul; 163(6):1214-22. PubMed ID: 21175570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats.
    Kirkedal C; Wegener G; Moreira F; Joca SRL; Liebenberg N
    Acta Neuropsychiatr; 2017 Dec; 29(6):324-329. PubMed ID: 27938441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
    Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
    Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the endovanilloid receptor, TRPV1, and of the endocannabinoid enzyme, FAAH, within the nucleus accumbens shell elicits anxiolytic-like effects in male rats.
    Pardo-García TR; Yusif-Rodriguez N; Yudowski G; Maldonado-Vlaar CS
    Neurosci Lett; 2020 Jul; 732():135023. PubMed ID: 32422166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis.
    Malek N; Mrugala M; Makuch W; Kolosowska N; Przewlocka B; Binkowski M; Czaja M; Morera E; Di Marzo V; Starowicz K
    Pain; 2015 May; 156(5):890-903. PubMed ID: 25719612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.